Valentin Barsan

Director/Board Member at Neuron23, Inc.

Commercial Services

Consumer Services

Technology Services

Profile

Valentin Barsan is currently a Director at Arsenal Biosciences, Inc. and Neuron23, Inc. He holds a doctorate degree from Baylor College of Medicine.

Valentin Barsan active positions

Companies	Position	Start
Neuron23, Inc. Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Neuron23, Inc. is a clinical-stage biotechnology company based in an undisclosed location. The American company's focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The company was founded by Adam Knight and Nancy E. Stagliano has been the CEO of the company since 2019.	Director/Board Member	30/03/2022
Arsenal Biosciences, Inc. Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA.	Director/Board Member	-

All active positions of Valentin Barsan

Training of Valentin Barsan

Baylor College of Medicine

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Valentin Barsan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Neuron23, Inc. Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Neuron23, Inc. is a clinical-stage biotechnology company based in an undisclosed location. The American company's focus areas are neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Neuron23 combines recent advances in human genetics with a state-of-the-art drug discovery and biomarker platform using advanced techniques in machine learning and artificial intelligence to advance therapeutics for devastating diseases. The company was founded by Adam Knight and Nancy E. Stagliano has been the CEO of the company since 2019.	Commercial Services
Arsenal Biosciences, Inc. Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA.	Technology Services